Index RUT P/E 13.81 EPS (ttm) 3.76 Insider Own 2.23% Shs Outstand 67.99M Perf Week -5.61%
Market Cap 3.53B Forward P/E 8.86 EPS next Y 5.87 Insider Trans -82.02% Shs Float 66.48M Perf Month -4.06%
Enterprise Value 3.45B PEG 17.93 EPS next Q 1.27 Inst Own 115.91% Short Float 11.33% Perf Quarter -33.20%
Income 271.00M P/S 2.32 EPS this Y -16.43% Inst Trans -2.22% Short Ratio 4.86 Perf Half Y -49.42%
Sales 1.52B P/B 3.03 EPS next Y 3.84% ROA 13.36% Short Interest 7.53M Perf YTD -41.90%
Book/sh 17.16 P/C 5.08 EPS next 5Y 0.77% ROE 24.71% 52W High 118.21 -56.03% Perf Year -50.03%
Cash/sh 10.23 P/FCF 7.42 EPS past 3/5Y - 40.75% ROIC 15.21% 52W Low 47.25 10.01% Perf 3Y -38.88%
Dividend Est. - EV/EBITDA 6.99 Sales past 3/5Y 53.37% 34.59% Gross Margin 63.75% Volatility 4.15% 3.58% Perf 5Y 300.15%
Dividend TTM - EV/Sales 2.27 EPS Y/Y TTM -37.03% Oper. Margin 28.47% ATR (14) 2.27 Perf 10Y 643.63%
Dividend Ex-Date - Quick Ratio 4.07 Sales Y/Y TTM 5.75% Profit Margin 17.82% RSI (14) 37.41 Recom 1.31
Dividend Gr. 3/5Y - - Current Ratio 4.29 EPS Q/Q 27.40% SMA20 -5.45% Beta 0.10 Target Price 86.64
Payout 0.00% Debt/Eq 0.53 Sales Q/Q -4.07% SMA50 -17.98% Rel Volume 0.64 Prev Close 51.74
Employees 808 LT Debt/Eq 0.53 Earnings Aug 06 BMO SMA200 -37.83% Avg Volume 1.55M Price 51.98
IPO Jun 25, 2015 Option/Short Yes / Yes EPS/Sales Surpr. -6.29% -2.55% Trades
Volume 992,617 Change 0.46%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-12-25 Downgrade Truist
Buy → Hold
$63
Dec-18-24 Initiated Goldman
Buy
$143
Sep-03-24 Initiated Redburn Atlantic
Buy
$175
Jul-10-24 Reiterated JMP Securities
Mkt Outperform
$100 → $130
Dec-18-23 Downgrade William Blair
Outperform → Mkt Perform
Dec-04-23 Initiated TD Cowen
Outperform
$100
Sep-29-23 Initiated William Blair
Outperform
Mar-08-23 Initiated JMP Securities
Mkt Outperform
$120
Nov-30-22 Initiated SVB Leerink
Outperform
Oct-13-22 Initiated Mizuho
Buy
$105
May-09-22 Initiated B. Riley Securities
Buy
$91
Apr-13-22 Initiated Truist
Buy
$77
Feb-01-21 Initiated SVB Leerink
Outperform
$24
Jun-29-20 Resumed Jefferies
Buy
$29
Aug-16-19 Upgrade CJS Securities
Market Perform → Market Outperform
Nov-02-17 Upgrade Wells Fargo
Market Perform → Outperform
Nov-08-16 Reiterated RBC Capital Mkts
Outperform
$6 → $12
Sep-23-16 Resumed Credit Suisse
Neutral
Feb-24-16 Reiterated RBC Capital Mkts
Outperform
$9 → $6
Dec-11-15 Downgrade Credit Suisse
Outperform → Neutral
Show Previous Ratings
Sep-15-25 11:31PM
Sep-09-25 12:02AM
Sep-02-25 08:30AM
04:05AM
Sep-01-25 12:38AM
12:26AM
Loading…
Aug-29-25 12:26AM
Aug-23-25 03:54AM
Aug-13-25 12:16PM
01:34AM
Aug-12-25 03:45PM
09:40AM
03:13AM
Aug-07-25 12:40PM
Aug-06-25 01:10PM
07:55AM
07:27AM
Loading…
07:27AM
(Associated Press Finance)
07:00AM
06:45AM
Aug-05-25 09:31AM
Aug-04-25 11:21PM
Jul-28-25 11:11AM
Jul-27-25 10:01AM
Jul-23-25 08:00AM
Jul-22-25 07:00AM
Jul-18-25 12:05AM
Jul-16-25 12:10PM
Jul-11-25 03:30PM
Jul-03-25 12:34AM
Jul-02-25 01:35AM
Jun-29-25 09:56PM
04:16AM
Loading…
Jun-28-25 04:16AM
Jun-24-25 03:09PM
Jun-23-25 11:31PM
Jun-11-25 04:01PM
Jun-10-25 08:30AM
Jun-03-25 08:30AM
Jun-02-25 08:00AM
May-14-25 08:30AM
May-09-25 10:32AM
May-08-25 06:20AM
05:03AM
03:09AM
12:49AM
(Thomson Reuters StreetEvents)
May-07-25 12:01PM
11:26AM
11:23AM
07:22AM
(Associated Press Finance)
07:00AM
May-06-25 04:01PM
06:20AM
Apr-30-25 08:30AM
Apr-27-25 03:29PM
Apr-23-25 08:30AM
Apr-19-25 05:30AM
Apr-09-25 12:57PM
Apr-01-25 09:00AM
Mar-27-25 12:03PM
Mar-23-25 12:00PM
Mar-20-25 12:00PM
Mar-14-25 12:10PM
Mar-10-25 05:01AM
Feb-27-25 02:06AM
Feb-26-25 10:35PM
(Thomson Reuters StreetEvents) +16.49%
01:06PM
08:06AM
07:20AM
(Associated Press Finance)
07:00AM
Feb-25-25 10:14AM
08:04AM
Feb-21-25 08:30AM
Feb-20-25 03:07PM
Feb-12-25 08:00AM
Feb-05-25 08:30AM
Feb-04-25 12:41PM
Feb-03-25 04:40PM
(Pharmaceutical Technology)
Jan-30-25 08:30AM
Jan-29-25 01:32PM
10:41AM
(Pharmaceutical Technology)
04:30AM
Jan-28-25 10:32AM
06:30AM
Jan-27-25 11:04AM
(Pharmaceutical Technology)
Jan-14-25 11:28AM
Jan-13-25 12:05AM
Jan-07-25 08:08AM
03:00AM
(Investor's Business Daily)
Dec-16-24 05:21PM
Dec-01-24 09:08AM
Nov-27-24 08:12AM
Nov-20-24 06:54PM
01:00AM
Nov-13-24 08:30AM
Nov-11-24 07:39AM
Nov-07-24 02:08AM
02:04AM
(Thomson Reuters StreetEvents)
Nov-06-24 07:13AM
(Associated Press Finance) -20.69%
07:00AM
Nov-05-24 07:38AM
Nov-04-24 07:30AM
Nov-01-24 03:31AM
Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
PATEL RAJIV A Member of a Group Owning 10% Aug 20 '25 Sale 56.15 3,365,000 188,944,750 3,477,227 Aug 21 05:27 PM PATEL RAJIV A Member of a Group Owning 10% Aug 19 '25 Sale 55.34 41,000 2,268,940 6,842,227 Aug 21 05:27 PM FARALLON PARTNERS L L C/CA Member of a Group Owning 10% Aug 20 '25 Sale 56.15 3,365,000 188,944,750 3,477,227 Aug 21 05:27 PM FARALLON PARTNERS L L C/CA Member of a Group Owning 10% Aug 19 '25 Sale 55.34 41,000 2,268,940 6,842,227 Aug 21 05:27 PM Blanchfield Paul President Aug 13 '25 Sale 53.57 3,060 163,924 108,214 Aug 15 04:33 PM Blanchfield Paul Officer Aug 13 '25 Proposed Sale 53.57 3,060 163,924 Aug 13 12:48 PM Niedzwiecki Daniel See Remarks Jun 13 '25 Sale 78.74 6,000 472,440 87,057 Jun 17 04:31 PM Niedzwiecki Daniel Officer Jun 13 '25 Proposed Sale 78.74 6,000 472,440 Jun 13 10:00 AM McHugh Julie Director Jun 09 '25 Sale 81.62 5,192 423,771 25,962 Jun 11 04:33 PM Marshall Robert J. Jr. CFO and Treasurer Jun 09 '25 Option Exercise 49.93 14,773 737,616 128,633 Jun 11 04:32 PM Marshall Robert J. Jr. CFO and Treasurer Jun 09 '25 Sale 83.00 39,773 3,301,296 88,860 Jun 11 04:32 PM Blanchfield Paul President Jun 05 '25 Sale 79.65 6,599 525,610 111,792 Jun 09 04:34 PM Niedzwiecki Daniel See Remarks Jun 05 '25 Sale 79.65 6,000 477,900 93,057 Jun 09 04:34 PM Marshall Robert J. Jr. Officer Jun 09 '25 Proposed Sale 81.62 39,773 3,246,272 Jun 09 11:11 AM McHugh Julie Director Jun 09 '25 Proposed Sale 81.62 5,192 423,771 Jun 09 10:06 AM Heino Mary Anne Director Jun 02 '25 Proposed Sale 76.73 26,066 1,999,957 Jun 05 12:35 PM Blanchfield Paul Officer Jun 05 '25 Proposed Sale 79.65 6,599 525,610 Jun 05 11:23 AM Niedzwiecki Daniel Officer Jun 05 '25 Proposed Sale 79.65 6,000 477,900 Jun 05 10:13 AM Heino Mary Anne Director Jun 02 '25 Sale 76.83 26,066 2,002,570 318,650 Jun 04 04:32 PM Marshall Robert J. Jr. CFO and Treasurer Mar 17 '25 Sale 100.52 10,000 1,005,200 113,860 Mar 19 06:44 PM Heino Mary Anne Director Mar 13 '25 Sale 100.13 2 200 8,618 Mar 17 08:09 PM Marshall Robert J. Jr. Officer Mar 17 '25 Proposed Sale 100.52 10,000 1,005,200 Mar 17 10:49 AM Blanchfield Paul President Mar 05 '25 Sale 98.00 2,084 204,232 91,828 Mar 07 05:44 PM Heino Mary Anne Director Mar 03 '25 Sale 94.35 53,107 5,010,734 440,399 Mar 05 05:09 PM Blanchfield Paul Officer Mar 05 '25 Proposed Sale 98.00 2,084 204,232 Mar 05 10:17 AM Heino Mary Anne Officer Mar 03 '25 Proposed Sale 91.00 53,200 4,841,200 Feb 28 03:31 PM Thrall James H Director Jan 15 '25 Sale 94.76 1,000 94,760 33,207 Jan 17 04:15 PM Thrall James H Director Jan 15 '25 Proposed Sale 94.76 1,000 94,760 Jan 15 09:59 AM MARKISON BRIAN A CEO Dec 19 '24 Option Exercise 9.15 32,768 299,983 185,594 Dec 23 07:33 PM Marshall Robert J. Jr. CFO and Treasurer Nov 15 '24 Sale 81.20 10,000 812,000 102,963 Nov 19 04:39 PM Blanchfield Paul President Nov 14 '24 Sale 79.65 2,000 159,300 97,092 Nov 18 05:36 PM Marshall Robert J. Jr. Officer Nov 15 '24 Proposed Sale 81.20 10,000 812,000 Nov 15 11:59 AM Blanchfield Paul Officer Nov 14 '24 Proposed Sale 79.65 2,000 159,300 Nov 14 10:07 AM Heino Mary Anne Director Nov 08 '24 Sale 87.16 11,487 1,001,218 443,436 Nov 12 05:41 PM Heino Mary Anne Officer Nov 08 '24 Proposed Sale 87.06 11,487 1,000,060 Nov 08 04:38 PM Sabens Andrea Officer Oct 14 '24 Proposed Sale 113.10 342 38,680 Oct 15 08:28 AM
